United States: SEC Charges Biopharmaceutical Executive With Insider Trading - Cadwalader, Wickersham & Taft LLP

The SEC alleged that, within minutes of receiving the information, the executive used his work computer to purchase out-of-the-money, short-term stock options in a peer company.